Target intelligence / Profile preview

FAD-linked sulfhydryl oxidase, mitochondrial (GFER)

Target
GFER
Molecular classification
Enzyme, Sulfhydryl oxidase, FAD-binding protein, Growth factor
01

Overview

FAD-linked sulfhydryl oxidase, mitochondrial, also known as Augmenter of Liver Regeneration (ALR) or GFER, is a multifunctional enzyme localized primarily in the mitochondrial intermembrane space. It is a central component of the Mitochondrial Intermembrane Space Import and Assembly (MIA) pathway, where it catalyzes the oxidation of Mia40, enabling the oxidative folding and entrapment of cysteine-rich proteins imported into the mitochondria (UniProt P55789). Beyond its role in mitochondrial biogenesis, GFER acts as a potent hepatotrophic growth factor that stimulates liver regeneration and exerts anti-apoptotic effects on hepatocytes through the activation of signaling pathways such as MAPK/ERK (PubMed: 22434774). In clinical contexts, GFER deficiency is linked to severe mitochondrial myopathy and lactic acidosis, while its dysregulation is associated with chronic liver diseases and the progression of hepatocellular carcinoma (NCBI Gene ID: 2621). Its therapeutic potential is being explored in the context of treating liver failure and mitigating mitochondrial dysfunction in metabolic and neurodegenerative disorders.

Other names
Augmenter of liver regenerationALRGrowth factor Erv1-likeHepatopoietinHPOSulfhydryl oxidase GFERERV1 homolog
02

Mechanism of action

Administration of recombinant protein to stimulate hepatocyte proliferation and provide cytoprotection; modulation of the mitochondrial disulfide relay system to restore proteostasis.

03

Biological functions

Mitochondrial protein importDisulfide bond formationLiver regenerationApoptosis regulationSpermatogenesisRedox homeostasis
04

Disease associations

Mitochondrial myopathyCombined oxidative phosphorylation deficiency 20Liver cirrhosisHepatocellular carcinomaAcute liver failureChronic kidney disease
05

Safety considerations

Potential for promoting tumor growth in hepatocellular carcinoma due to its proliferative effectsRisk of off-target effects on systemic redox signalingSevere developmental defects associated with loss-of-function mutations
06

Interacting drugs

Recombinant human Augmenter of Liver Regeneration (rhALR)
07

Biomarkers

Serum ALR levelsMitochondrial DNA depletionUrinary GFER excretion

Beyond the preview

Go deeper on FAD-linked sulfhydryl oxidase, mitochondrial (GFER).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FAD-linked sulfhydryl oxidase, mitochondrial (GFER).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call